Genetic
1963, France — Jerome Lejeune, Marthe Gautier, and colleagues, Paris
Cri du chat syndrome entered the medical literature in the early 1960s when chromosomal analysis techniques first became sophisticated enough to detect the small deletion on chromosome 5 responsible for the condition. Before that technological threshold, affected individuals had been observed and variously categorized, but the unifying biological explanation remained entirely out of reach. The syndrome's discovery is a chapter in the broader mid-twentieth century revolution in human cytogenetics.
Historical Narrative
Before the molecular era of genetics, physicians encountering children with the characteristic features associated with what would eventually be called cri du chat syndrome had no framework within which to unite those features into a coherent diagnosis with a single cause. Ancient and medieval physicians who observed children with intellectual disabilities and unusual physical features interpreted such presentations through available explanatory systems — divine punishment, maternal impression during pregnancy, astrological influence, or the workings of fate. The wide spectrum of conditions now recognized as chromosomal disorders would have been scattered across diverse diagnostic categories in historical records, if documented at all, with affected children often described in terms of their perceived resemblance to folkloric figures or through religiously inflected language.
The eighteenth and nineteenth centuries saw the emergence of more systematic approaches to categorizing intellectual disability and developmental difference. Physicians at institutions for individuals with intellectual disabilities in France, Britain, and elsewhere began producing detailed clinical descriptions and taxonomies. John Langdon Down, working at Earlswood Asylum in England during the 1860s, made significant contributions to the clinical classification of intellectual disability, and while his work focused on what would later be identified as Down syndrome, his methodological approach of careful clinical observation and categorization influenced subsequent generations of physicians who worked to describe other developmental conditions.
The decisive transformation came with advances in human cytogenetics in the late 1950s. In 1956, Joe Hin Tjio and Albert Levan established the correct human chromosome number as 46, correcting a longstanding error, and within just a few years Jerome Lejeune, Marthe Gautier, and Raymond Turpin in Paris had identified the chromosomal basis of Down syndrome in 1959, demonstrating for the first time that a human clinical condition could result from a chromosomal abnormality visible under a microscope. This discovery opened a period of rapid chromosomal exploration.
Jerome Lejeune, working with his colleagues in Paris, identified cri du chat syndrome in 1963, describing the condition in a paper that connected a specific clinical picture — including the distinctive high-pitched cry in infancy that gave the syndrome its French name meaning 'cry of the cat' — to a deletion of material from the short arm of chromosome 5. Lejeune was already celebrated for his work on Down syndrome, and his identification of cri du chat syndrome further cemented his reputation as a founder of clinical cytogenetics. The 1963 paper was groundbreaking because it demonstrated that partial chromosomal deletions, not just the presence of an extra chromosome, could produce defined clinical syndromes.
In the years following Lejeune's discovery, researchers worked to refine the understanding of which portion of chromosome 5 was deleted in affected individuals and to correlate the size and position of deletions with the range of features observed. Cytogeneticists across Europe and North America contributed case series and refinements to the chromosomal mapping of the deletion throughout the 1960s and 1970s, gradually building a more precise picture of the condition's genetic geography. The syndrome thus became an important early model for understanding how chromosomal deletions produce recognizable clinical entities, a principle that proved foundational for the subsequent development of the field of contiguous gene syndromes.
Key Historical Figures
Historical narrative only — this page describes how Cri du chat syndrome was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.